The role of nutritional status in the outcome of peritoneal dialysis patients

Panminerva Medica

Volumn 51, Issue 3, 2009, Pages 163-173

  Grzegorzewska, A E ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Body mass index; Nutrition; Outcome; Peritoneal dialysis; Treatment

Indexed keywords

ARTICLE; BODY COMPOSITION; BODY MASS; CHRONIC KIDNEY FAILURE; HUMAN; MALNUTRITION; MORTALITY; NUTRITIONAL STATUS; OBESITY; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; TREATMENT OUTCOME; COMPLICATION; KIDNEY FAILURE, CHRONIC;

BODY COMPOSITION; BODY MASS INDEX; HUMANS; KIDNEY FAILURE, CHRONIC; MALNUTRITION; NUTRITIONAL STATUS; OBESITY; PERITONEAL DIALYSIS; TREATMENT OUTCOME;

EID: 76749105648     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (121)

1. Dong J, Wang T, Han Q, Wang H. Impact of nutritional status, inflammation and cardiovascular disease on the mortality of 90 Chinese peritoneal dialysis patients [Article in Chinese]. Beijing Da Xue Xue Bao 2003;35:645-8.
2. Chung SH, Lindholm B, Lee HB. Is malnutrition an independent predictor of mortality in peritoneal dialysis patients? Nephrol Dial Transplant 2003;18:2134-40.
3. De Lima JJ, da Fonseca JA, Godoy AD. Baseline variables associated with early death and extended survival on dialysis. Ren Fail 1998;20:581-7.
4. Avram MM, Goldwasser P, Erroa M, Fein PA. Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of prealbumin and other nutritional and metabolic parameters. Am J Kidney Dis 1994;23:91-8.
5. Lowrie EG, Huang WH, Lew NL. Death risk predictors among peritoneal dialysis and hemodialysis patients: a preliminary comparison. Am J Kidney Dis 1995;26:220-8.
6. Canada-USA (CANUSA) Peritoneal Dialysis Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcome. J Am Soc Nephrol 1996;7:198-207.
7. Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996;7:2176-82.
8. Avram MM, Fein PA, Bonomini L, Mittman N, Loutoby R, Avram DK, et al. Predictors of survival in continuous ambulatory peritoneal dialysis patients: a five year prospective study. Perit Dial Int 1996; 16(Suppl 1):S190-4.
9. Fried L, Bernardini J, Piraino B. Neither size nor weight predicts survival in peritoneal dialysis patients. Perit Dial Int 1996;16:357-61.
10. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002;13:1307-20.
11. Kutner NG, Zhang R. Body mass index as a predictor of continued sur-vival in older chronic dialysis patients. Int Urol Nephrol 2001;32:441-8.
12. Struijk DG, Krediet RT, Koomen GC, Boeschoten EW, Arisz L. The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Perit Dial Int 1994;14:121-6.
13. Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT. Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am J Kidney Dis 2000;35:69-79.
14. Szeto CC, Wong TY, Leung CB, Wang AY, Law MC, Lui SF, et al. Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 2000;58:400-7.
15. Cueto-Manzano AM, Quintana-Pina E, Correa-Rotter R. Long-term CAPD survival and analysis of mortality risk factors: 12-year experience of a single center. Perit Dial Int 2001;21:148-53.
16. Hung CC, Chang CT, Lee CC, Chen KH, Yu CC, Wu CH, et al. Prognostic predictors of technique and patient survival in elderly Southeast Asian patients undergoing continuous ambulatory peritoneal dialysis. Int J Clin Pract 2009;63:254-60.
17. Dong J, Li YJ, Lu XH, Gan HP, Zuo L, Wang HY Correlations of lean body mass with nutritional indicators and mortality in patients on peritoneal dialysis. Kidney Int 2008;73:334-40.
18. Noh H, Lee SW, Kang SW, Shin SK, Choi KH, Lee HY, et al. Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1998;18:387-94.
19. Pecoits-Filho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 2002; 17:1684-8.
20. Wang T, Heimbürger O, Waniewski J, Bergström J, Lindholm B. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998;13:1242-9.
21. Johnson DW, Herzig KA, Purdie DM, Chang W, Brown AM, Rigby RJ, et al. Is obesity a favorable prognostic factor in peritoneal dialysis patients? Perit Dial Int 2000;20:715-21.
22. Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ. Body size and outcomes on peritoneal dialysis in the United States. Kidney Int 2003;64:1838-44.
23. McDonald SP, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol 2003; 14:2894-901.
24. Abbott KC, Glanton CW, Trespalacios FC, Oliver DK, Ortiz MI, Agodoa LY, et al. Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int 2004;65:597-605.
25. Stack AG, Murthy BV, Molony DA. Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States. Kidney Int 2004;65:2398-408.
26. de Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW; Netherlands Cooperative Study on the Adequacy of Dialysis-II Study Group. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr 2009; 19:127-35.
27. Carvounis CP, Manis T, Coritsidis G, Dubinsky M, Serpente P. Total lymphocyte count: a promising prognostic index of mortality in patients on CAPD. Perit Dial Int 2000;20:33-8.
28. Prasad N, Gupta A, Sharma RK, Sinha A, Kumar R. Impact of nutritional status on peritonitis in CAPD patients. Perit Dial Int 2007;27:42-7.
29. WHO. Malnutrition-The Global Picture. World Health Organization. Available at http://www.who.int/home-page/.
30. http://kidshealth.org/teen/food-fitness/nutrition/hunger.html. 25 July, 2009 GMT.
31. Soeters PB, Schols AM. Advances in understanding and assessing malnutrition. Curr Opin Clin Nutr Metab Care 2009 Jun 8. [Epub ahead of print]
32. Li PKT, Kwan BCH, Szeto CC, Ko GTC. Metabolic syndrome in peritoneal dialysis patients. Nephrol Dial Transplant Plus 2008;1:206-14.
33. Detsky AS, Baker JP, Mendelson RA, Wolman SL, Wesson DE, Jeejeebhoy KN. Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons. J Parenter Enteral Nutr 1984;8:153-9.
34. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000;35(6 Suppl 2):Sl-140.
35. Fouque D, Vennegoor M, ter Wee P, Wanner C, Basci A, Canaud B, et al. EBPG guideline on nutrition. Nephrol Dial Transplant 2007;22(Suppl 2):ii45-87.
36. Steiber A, Leon JB, Seker D, McCarthy M, McCann L, Serra M, et al. Multicenter study of the validity and reliability of subjective global assessment in the hemodialysis population. J Ren Nutr 2007; 17:336-42.
37. Li Y, Dong J, Zuo L. Is subjective global assessment a good index of nutrition in peritoneal dialysis patients with gastrointestinal symptoms? Perit Dial Int 2009;29(Suppl 2):S78-82.
38. Cooper BA, Bartlett LH, Aslani A, Allen BJ, Ibels LS, Pollock CA. Validity of subjective global assessment as a nutritional marker in end-stage renal disease. Am J Kidney Dis 2002;40:126-32.
39. Foley RN. Body mass index and survival in peritoneal dialysis patients. Perit Dial Int 2005;25:435-7.
40. Prasad N, Gupta A, Sinha A, Sharma RK, Kumar A, Kumar R. Changes in nutritional status on follow-up of an incident cohort of continuous ambulatory peritoneal dialysis patients. J Ren Nutr 2008;18:195-201.
41. Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vecchi A, Scalamogna A, et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis 1991;17:462-71.
42. Aslam N, Bernardini J, Fried L, Piraino B. Large body mass index does not predict short-term survival in peritoneal dialysis patients. Perit Dial Int 2002;22:191-6.
43. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097-105.
44. Grzegorzewska AE, Leander M. Possible factors contributing to similar peritoneal dialysis outcome in patients over 60 years of age and the younger ones. Int Urol Nephrol 2002-2003;34:565-72.
45. Kalantar-Zadeh K, Kuwae N, Wu DY, Shantouf RS, Fouque D, Anker SD, et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 2006;83:202-10.
46. Axelsson J, Heimburger O, Lindholm B, Stenvinkel P. Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr 2005;15:131-6.
47. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005;165:55-61.
48. Axelsson J, Rashid Qureshi A, Suliman ME, Honda H, Pecoits-Filho R, Heimbürger O, et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 2004;80:1222-9.
49. Axelsson J, Heimbürger O, Stenvinkel P. Adipose tissue and inflammation in chronic kidney disease. Contrib Nephrol 2006;151:165-74.
50. Morabia A, Ross A, Curtin F, Pichard C, Slosman DO. Relation of BMI to a dual-energy X-ray absorptiometry measure of fatness. Br J Nutr 1999;82:49-55.
51. Ramkumar N, Pappas LM, Beddhu S. Effect of body size and body composition on survival in peritoneal dialysis patients. Perit Dial Int 2005;25:461-9.
52. McDonald SP, Collins JF, Rumpsfeld M, Johnson DW. Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int 2004;24:340-6.
53. Chen HY, Kao TW, Huang JW, Chu TS, Wu KD. Correlation of metabolic syndrome with residual renal function, solute transport rate and peritoneal solute clearance in chronic peritoneal dialysis patients. Blood Purif 2008;26:138-44.
54. Grzegorzewska AE, Mariak I. Differences in clinical and laboratory data of peritoneal dialysis patients selected according to body mass index. Adv Perit Dial 2003; 19:222-6.
55. Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, et al. Predictors of decline of residual renal function in new peritoneal dialysis patients. Perit Dial Int 2003;23:276-83.
56. Zimmet P, Alberti G, Shaw J. A new IDF worldwide definition of the metabolic syndrome: the rationale and the results. Diabetes Voice 2005;50:31-3.
57. Johnson DW, Armstrong K, Campbell SB, Mudge DW, Hawley CM, Coombes JS, et al. Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) 2007;12:391-8.
58. Park SH, Lindholm B. Definition of metabolic syndrome in peritoneal dialysis. Perit Dial Int 2009;29(Suppl 2):S 137-44.
59. http://www.britannica.com/EBchecked/topic/563746/starvation. 1 August, 2009 GMT.
60. Muscaritoli M, Molfino A, Bollea MR, Fanelli FR. Malnutrition and wasting in renal disease. Curr Opin Clin Nutr Metab Care 2009;12:378-83.
61. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008;73:391-8.
62. Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr 2008;27:793-9.
63. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-911.
64. Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000;15:953-60.
65. Shahab I, Nolph KD. MIA syndrome in peritoneal dialysis: prevention and treatment. Contrib Nephrol 2006;150:135-43.
66. Baltzan MA, Shoker AS. Malnutrition and dialysis (letter). Kidney Int 1998;53:999.
67. Lee SW, Park GH, Lee SW, Song JH, Hong KC, Kim MJ. Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients. Nephrol Dial Transplant 2007; 22: 2554-62.
68. Siew ED, Pupim LB, Majchrzak KM, Shintani A, Flakoll PJ, Ikizler TA. Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int 2007;71:146-52.
69. Prasad N, Gupta A, Sinha A, Singh A, Sharma RK, Kaul A. Impact of stratification of comorbidities on nutrition indices and survival in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2009;29(Suppl 2):S153-7.
70. Pajek J, Gucek A, Kveder R, Bucar-Pajek M, Kaplan-Pavlovcic S, Bren AF. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients. J Ren Nutr 2008; 18:503-8.
71. Blumberg A, Hanck A, Sander G. Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1983;20:244-50.
72. Boeschoten EW, Schrijver J, Krediet RT, Schreurs WH, Arisz L. Deficiencies of vitamins in CAPD patients: the effect of supplementation. Nephrol Dial Transplant 1988;3:187-93.
73. Lee EJ, Myint CC, Tay ME, Yusuf N, Ong CN. Serum ascorbic acid and protein calorie malnutrition in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2001;17:219-22.
74. Wang AY, Lam CW, Sanderson JE, Wang M, Chan IH, Lui SF, et al. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin Nutr 2008;87:1631-8.
75. Hörl WH. Anemia and its treatment in peritoneal dialysis patients [Article in German]. Wien Klin Wochenschr 2005;117(Suppl 6):69-72.
76. Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Ilic M, Stokiç E. Metabolic syndrome in HD patients: association with body composition, nutritional status, inflammation and serum iron. Intern Med 2007;46:945-51.
77. Zima T, Mestek O, ecek, Bártová V, Fialová J, Tesar V, et al. Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients. Blood Purif 1998;16:253-60.
78. Lane E, Holden AJ, Coward RA. Determination of copper and zinc in blood plasma by ion chromatography using a cobalt internal standard. Analyst 1999;124:245-9.
79. Apostolidis NS, Panoussopoulos DG, Stamou KM, Kekis PB, Paradellis TP, Karydas AG, et al. Selenium metabolism in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2002;22:400-4.
80. Grzegorzewska AE, Mariak I. Zinc as a marker of nutrition in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2001;17:223-9.
81. Munguía C, Paniagua R, Avila-Díaz M, Nava-Hernández J, Rodríguez E, Ventura Mde J, et al. Effect of zinc supplements on the nutritional status of patients undergoing continuous ambulatory peritoneal dialysis [Article in Spanish]. Rev Invest Clin 2003;55:519-27.
82. Grzegorzewska AE. Laboratory markers of nutritional state in patients treated with peritoneal dialysis [Article in Polish]. Pol Merk Lek 2009;27:157-160.
83. Grzegorzewska AE, Leander M. Total lymphocyte count and subpopulation lymphocyte counts in relation to dietary intake and nutritional status of peritoneal dialysis patients. Adv Perit Dial 2005;21:35-40.
84. Gamba G, Mejia JL, Saldivar S, Pena JC, Correa-Rotter R. Death risk in CAPD patients. The predictive value of the initial clinical and laboratory variables. Nephron 1993;65:23-7.
85. Cueto-Manzano AM, Correa-Rotter R. Is high peritoneal transport rate an independent risk factor for CAPD mortality? Kidney Int 2000;57:314-20.
86. Sánchez-González MC, López-Barea F, Bajo MA, Seigas R; Collaborators of the Multicenter Study Group. Serum albumin levels, an additional factor implicated in hyperparathyroidism outcome in peritoneal dialysis: a prospective study with paired bone biopsies. Adv Perit Dial 2006;22:198-202.
87. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, et al. Protein losses during peritoneal dialysis. Kidney Int 1981:19:593-602.
88. Sucharzewska-Tomczak M, Grzegorzewska AE, Leander M. Serum concentration of haptoglobin, adequacy of peritoneal dialysis, and nutrition status of patients with and without diabetes on peritoneal dialysis. Adv Perit Dial 2003;19:246-50.
89. Grzegorzewska AE, Mlot M, Leander M. Serum levels of cancer antigen 125 and interleukin-15 in relation to the nutrition status of peritoneal dialysis patients. Adv Perit Dial 2004;20:185-9.
90. Díaz A, Gamba G, Abasta-Jiménez M, Correa-Rotter R. Serum albumin and body surface area are the strongest predictors of the peritoneal transport type. Adv Perit Dial 1994; 10:47-51.
91. Margetts PJ, McMullin JP, Rabbat CG, Churchill DN. Peritoneal membrane transport and hypoalbuminemia: cause or effect? Perit Dial Int 2000;20:14-8.
92. Cueto-Manzano AM, Gamba G, Correa-Rotter R. Peritoneal protein loss in patients with high peritoneal permeability. Comparison between continuous ambulatory peritoneal dialysis and daytime intermittent dialysis. Arch Med Res 2001;32:197-201.
93. Cueto-Manzano AM, Salazar M, Valera-Gonzalez I, Rojas-Campos E, Martinez-Ramirez HR, Cortes-Sanabria L, et al. Association between the peritoneal transport rate and systemic inflammation marker in continuous ambulatory peritoneal dialysis (CAPD) [Abstract]. J Am Soc Nephrol 2002; 13:201 A.
94. Jones CH, Wells L, Stoves J, Farquhar F, Woodrow G. Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients? Am J Kidney Dis 2002;39:872-5.
95. Cueto-Manzano AM, Espinosa A, Hernández A, Correa-Rotter R. Peritoneal transport kinetics correlate with serum albumin but not with the overall nutritional status in CAPD patients. Am J Kidney Dis 1997;30:229-36.
96. Szeto CC, Law MC, Wong TY, Leung CB, Li PK. Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients: a 2-year prospective study. Am J Kidney Dis 2001;37:329-36.
97. Steinman TI. Serum albumin: its significance in patients with ESRD. Semin Dial 2000;13:404-8.
98. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 2004;291:451-9.
99. Sharma RK, Sahu KM. Nutrition in dialysis patients. J Indian Med Assoc 2001;99:206-8, 210-1, 213.
100. Giordano C, De Santo G, Pluvio M, Di LA, Capodicasa G, Cirillo D, Esposito R, Damiano M: Protein requirement of patients on CAPD: A study on nitrogen balance. Int J Artif Organs 1980:3:11-14.
101. Kopple JD, Gao XL, Qing DP: Dietary protein, urea nitrogen appearance and total nitrogen appearance in chronic renal failure and CAPD patients. Kidney Int 1997;52:486-94.
102. Bergstrom J, Heimburger O, Lindholm B. Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? Perit Dial Int 1998;18:467-73.
103. Kopple JD; National Kidney Foundation K/DOQI Work Group. The National Kidney Foundation K/DOQI clinical practice guidelines for dietary protein intake for chronic dialysis patients. Am J Kidney Dis 2001; 38(4 Suppl 1):S68-73.
104. Kopple JD. National Kidney Foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2001;37(1 Suppl 2):S66-70.
105. González-Espinoza L, Gutiérrez-Chávez J, del Campo FM, Martínez-Ramírez HR, Cortés-Sanabria L, Rojas-Campos E, et al. Randomized, open label, controlled clinical trial of oral administration of an egg albumin-based protein supplement to patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2005;25:173-80.
106. Jiang N, Qian J, Sun W, Lin A, Cao L, Wang Q, et al. Better preservation of residual renal function in peritoneal dialysis patients treated with a low-protein diet supplemented with keto acids: a prospective, randomized trial. Nephrol Dial Transplant 2009;24:2551-8.
107. Fein PA, Madane SJ, Jorden A, Babu K, Mushnick R, Avram MM, et al. Outcome of percutaneous endoscopic gastrostomy feeding in patients on peritoneal dialysis. Adv Perit Dial 2001;17:148-52.
108. Li FK, Chan LY, Woo JC, Ho SK, Lo WK, Lai KN, et al. A 3?year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis 2003;42:173?83.
109. Tjiong HL, Swart R, van den Berg JW, Fieren MW. Amino Acid-based peritoneal dialysis solutions for malnutrition: new perspectives. Perit Dial Int 2009;29:384-93.
110. Stein G, Sperschneider H, Koppe S. Vitamin levels in chronic renal failure and need for supplementation. Blood Purif 1985;3:52-62.
111. Hung SC, Hung SH, Tarng DC, Yang WC, Chen TW, Huang TP. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 2001;38:941-7.
112. Lim SL, Lee EJ, Myint CC, Ong KT, Tay ME, Yusuf N, et al. Oral intake and serum levels of ascorbic acid in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2001;17:215-8.
113. Singer R, Rhodes HC, Chin G, Kulkami H, Ferrari P. High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population. Nephrology (Carlton) 2008; 13:17-22.
114. Fissell RB, Bragg-Gresham JL, Gillespie BW, Goodkin DA, Bommer J, Saito A, et al. International variations in vitamin prescription and association with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004;44: 293-9.
115. Kopple JD, Blumenkrantz MJ, Jones MR, Moran JK, Coburn JW: Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am J Clin Nutr 1982:36:395-402.
116. Davies SJ, Phillips L, Griffiths AM, Naish PF, Russell GI. Analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients. Kidney Int 2000;57:1743-54.
117. Grzegorzewska AE, Leander M, Mlot-Michalska. Nutritional status of peritoneal dialysis patients and parameters of dialysis adequacy [Article in Polish]. Pol Arch Med Wewn 2006;116:736-40.
118. Grzegorzewska AE, Mariak I, Dobrowolska-Zachwieja A. Differences in assessment of patients with satisfactory or complicated continuous ambulatory peritoneal dialysis courses. Adv Perit Dial 1999; 15:116-20.
119. Jovanoviçv N, Lauseviç, Stojimiroviç. Residual renal function and nutritional status in patients on continuous ambulatory peritoneal dialysis [Article in Serbian]. Med Pregl 2005;58:576-81.
120. Fouque D, Peng SC, Shamir E, Kopple JD. Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients. Kidney Int 2000;57:646-54.
121. Hollis J, Corden E, Williams PF. Longitudinal evaluation of a weight reduction program for patients on peritoneal dialysis. Perit Dial Int 2005;25(Suppl 3):S152-4.